Len Schleifer
Co-founder, President & CEO of Regeneron Pharmaceuticals, MD-PhD who built the biotech behind Dupixent, Eylea, and the COVID antibody cocktail used to treat President Trump.
2
APPEARANCES
2
PODCASTS
Jun 2, 2026
Mike RockefellerHOST
Take us back to 1988 when you started the company, what the vision was and maybe how that has turned into what Regeneron is today.
Len SchleiferGUEST
So a couple of people in my family keep track of who's the longest continuous serving CEO of a large public company.
Len SchleiferGUEST
I just ran into Warren at a conference and I thanked him for retiring because that moved me up in the longest serving CEO, continuous labor public position.
38 MINS LATER
Becky QuickHOST
Should there be an opt-in policy instead of an opt-out policy as it exists today? How do I know that you're going to protect my safety and my standards and my privacy?
Len SchleiferGUEST
Yeah, you know, the details of the consent forms and what have you is something that the court is looking over very carefully.
Len SchleiferGUEST
As far as if we were the winner, I think we have a long history of protecting people's genetic and other health information, and we take that extremely seriously.
Len SchleiferGUEST
You know, there's a commission called the National Security Commission on Emerging Biotechnology.
5 MINS LATER
